The results of this week’s poll about the Affordable Care Act.
This week, we asked our readers for their opinions on whether the Affordable Care Act (ACA) will help Biden and the Democrats in the 2024 presidential election.
Almost all (80%) of our audience agreed that the ACA will help Biden secure a second presidential term, although he is running behind in many polls.
Last week, the Democrats celebrated the 14th anniversary of the ACA.
We want to know what you’re thinking! Every Monday morning the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. Answers will be published every Friday.
Two Opdivo Updates from Bristol Myers Squibb
May 14th 2024First approved by the U.S. Food and Drug Administration (FDA) in 2014, Opdivo has multiple indications across various types of cancer, including NSCLC, melanoma, renal cell carcinoma, Hodgkin lymphoma, squamous cell carcinoma of the head and neck, and urothelial carcinoma.
Read More
This data is based off of a study conducted by a group of researchers led by Niklas Frahm from the German Multiple Sclerosis Registry to compare the characteristics of patients with MS who switched from their first disease-modifying therapies (DMT) with those of patients who continued taking their first DMT.
Read More